Skip to main content


Join Us Next Year in Boston - October 4-6!

Thank you for attending the 2023 Annual Congress. Your participation contributed to the success of our event, fostering information sharing, collaboration, and innovation. We hope you had an enriching experience, engaging in insightful discussions and gaining practical knowledge to enhance your current strategies and policies.

Join 400+ cancer care professionals in Boston
Uniting Leaders to Provide More Cost-Efficient, Better Quality, and Improved Access to Care.

The business of oncology is constantly evolving and plagued with ongoing and unrelenting challenges in the pursuit of delivering and paying for high-quality cancer care.

We invite you to clarify your approach by exploring and deliberating strategies at the Clinical Pathways Congress + CBEx on October 6-8 in Boston.   

The Congress convenes 400+ providers, insurers, technology platforms, pathway providers, and industry experts for an exclusive 3-day program to address the pressing questions and complex topics to reimagine how the industry will deliver and pay for cancer care.

Together, we will delve into complex topics such as the role of AI in oncology, the significance of and barriers to effective clinical trial recruitment in the community setting, the power and impact of vertical integration, trends in practice consolidation, the EOM outlook from diverging perspectives, and so much more.

Klein Testimonial
McKinney Testimonial

Congress Resources

Conference Leaders

Alan Balch, PhD
Patient Advocate Foundation & National Patient Advocate Foundation
Hampton, VA
Carla Balch, MS
Memphis, TN
Ronald Barkley, MS, JD
Cancer Center Business Development Group
Indian River Shores, FL
Alexis Bortniker, JD
Foley & Lardner LLP
San Diego, CA
Nina Chavez, MBA
Flatiron Health
Albuquerque, NM
Rushir Choksi, MD
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, PA
Stephen B. Edge, MD, FACS, FASCO
Jacobs School of Medicine, University at Buffalo
Buffalo, NY
James Hamrick, MD, MPH
Flatiron Health
Atlanta, GA
John E. Hennessy, MBA
Valuate Health Consultancy
Overland Park, KS
Andrew Hertler, MD, FACP
New Century Health
Brea, CA
Manasi Kapoor, MBA
Memorial Sloan Kettering
New York, NY
Ira Klein, MD
Tempus Labs
Chicago, IL
Wui-Jin Koh, MD
National Comprehensive Cancer Network
Ft. Washington, PA
Michael Kolodziej, MD
Senior Advisor
Washington, DC
Harlan Levine, MD
City of Hope
Duarte, CA
Barbara McAneny, MD
New Mexico Oncology Hematology Consultants
Albuquerque, NM
Erich Mounce, MSHA
Oncology Care Partners
La Grange, TN
Ed Rodgers
Pittsburgh, PA
Barry Russo, MBA
The Center for Cancer and Blood Disorders
Fort Worth, TX
Deirdre Saulet, PhD
Market Vice President of Oncology
Carrum Health
Richmond, VA
Frederick M. Schnell, MD, FACP
National Cancer Treatment Alliance/Community Oncology Alliance
Washington, DC
Todd Schonherz
American Oncology Network
Fort Meyers, FL
Mahek A. Shah, MD, MBA, MS
Harvard Business School
Harvard School of Public Health and Brigham Health, Ariadne Labs
Boston, MA
Adria Warren, JD
Foley & Lardner LLP
Boston, MA
Robin T. Zon, MD, FACP, FASCO
Michiana Hematology-Oncology, PC
Mishawaka, Indiana
Who Should Attend?

If you are involved in any stage of the pathways process or any aspect of cancer care, register today to gain insight, ask questions, measure outcomes, and explore ways to partner and expand pathway programs.

Oncologists, Hematologists, Oncology Pharmacists, Oncology Nurses
Reimbursement Managers / Specialists
Cancer Care Team Members
Oncology Practice Managers
Pathway Development Executives
Commercial Payer
Pharmacy Benefit Management Organizations
Technology & Consultant Service Providers
Employer Groups / Coalitions
Oncology Practice and Health System
Hospital Executives
Students, Residents, & Fellows

Sign up for Updates